Nutra Pharma Corp. filed its 10-K on Feb 05, 2021 for the period ending Dec 31, 2018. In this report its auditor, Rotenberg Meril Solomon Bertiger & Guttilla, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
22/03 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
22/03 | Nutra Pharma Corporation Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 7L | |
+29.77% | 4.95TCr | |
+1.00% | 4.26TCr | |
+49.39% | 4.25TCr | |
-5.26% | 2.91TCr | |
+13.68% | 2.66TCr | |
-22.99% | 1.86TCr | |
+8.22% | 1.32TCr | |
+32.41% | 1.25TCr | |
+24.01% | 1.21TCr |
- Stock Market
- Equities
- NPHC Stock
- News Nutra Pharma Corp.
- Nutra Pharma Corp. Auditor Raises 'Going Concern' Doubt